Is Cardiofaciocutaneous / Cfc Syndrome hereditary?

Cardiofaciocutaneous (CFC) syndrome is a genetic condition that is almost always caused by a de novo (spontaneous) mutation rather than being inherited from a parent. Because affected individuals rarely reproduce, the condition is typically not hereditary, meaning there is a very low chance of the mutation being passed down to future children.

Is Cardiofaciocutaneous (CFC) syndrome hereditary?

While Cardiofaciocutaneous (CFC) syndrome is a genetic condition, it is rarely hereditary. Genetic conditions are caused by changes in DNA, but "hereditary" implies the condition was passed from parent to child. In the vast majority of cases, Cardiofaciocutaneous (CFC) syndrome occurs due to a de novo mutation, meaning the genetic change happens spontaneously in the egg or sperm cell at the time of conception. It is not caused by anything the parents did or did not do before or during pregnancy.

What causes the genetic changes in CFC syndrome?

Cardiofaciocutaneous (CFC) syndrome is caused by mutations in one of four specific genes involved in the RAS/MAPK signaling pathway: BRAF, MAP2K1, MAP2K2, or KRAS. These pathways are essential for normal cell division and growth. Because these mutations are de novo, the recurrence risk for siblings of a child with Cardiofaciocutaneous (CFC) syndrome is generally considered to be less than 1%.

How is genetic testing used for diagnosis and family planning?

Genetic testing is the gold standard for confirming a diagnosis of Cardiofaciocutaneous (CFC) syndrome. Clinical geneticists use molecular testing, such as multigene panel sequencing, to identify the specific mutation in the RAS/MAPK pathway. Genetic counseling is highly recommended for families to understand these results. Key considerations include:

• Diagnostic confirmation: Precise identification of the gene mutation aids in clinical management and long-term care planning.


• Reproductive options: For families who have had one child with the syndrome, counseling can provide clarity on the extremely low recurrence risk.


• Testing availability: Specialized laboratories offer targeted testing for the genes associated with Cardiofaciocutaneous (CFC) syndrome.

Next steps

• Consult with a board-certified clinical geneticist to discuss testing and personalized risk assessments.


• Connect with the 36 members of the Cardiofaciocutaneous (CFC) syndrome community at DiseaseMaps.org to share experiences and coping strategies.


• Request a referral to a multidisciplinary care team that includes cardiologists, dermatologists, and neurologists familiar with rare RASopathies.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cardiofaciocutaneous syndrome.


• Orphanet: Cardiofaciocutaneous syndrome (ORPHA:1396).


• OMIM (Online Mendelian Inheritance in Man): Cardiofaciocutaneous syndrome (#115150).


• CFC International: Resources and research updates for families.